Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington’s disease via the nasal-brain route

Objective: To propose a theoretical formulation of engeletin-nanostructured lipid nanocarriers for improved delivery and increased bioavailability in treating Huntington’s disease (HD). Methods: We conducted a literature review of the pathophysiology of HD and the limitations of currently available...

Descripción completa

Detalles Bibliográficos
Autores principales: Smriti, Singla, Madhav, Gupta, Saurabh, Porwal, Omji, Nasser Binjawhar, Dalal, Sayed, Amany A., Mittal, Pooja, El-Demerdash, Fatma M., Algahtani, Mohammad, Singh, Sachin Kumar, Dua, Kamal, Gupta, Gaurav, Bawa, Puneet, Altyar, Ahmed E., Abdel-Daim, Mohamed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364480/
https://www.ncbi.nlm.nih.gov/pubmed/37492081
http://dx.doi.org/10.3389/fphar.2023.1218625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364480/
https://www.ncbi.nlm.nih.gov/pubmed/37492081
http://dx.doi.org/10.3389/fphar.2023.1218625

Ejemplares similares